InvestorsHub Logo
Followers 78
Posts 11422
Boards Moderated 0
Alias Born 04/03/2014

Re: Amatuer17 post# 5889

Monday, 07/31/2017 8:04:58 PM

Monday, July 31, 2017 8:04:58 PM

Post# of 8449
Submitting NDA is a big deal for any company - more so for such a small company.

Also the icing on cake - $ 2 million registration fee waiver

"TEL AVIV, Israel, April 3, 2017 /PRNewswire/ --

Kitov Pharmaceuticals Holdings Ltd. (NASDAQ: KTOV, TASE: KTOV), an innovative biopharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has granted Kitov a waiver related to the $2,038,100 New Drug Application (NDA 210045) filing fee for KIT-302.
KIT-302 is Kitov's patented combination of Amlodipine Besylate-Celecoxib tablets, intended to treat osteoarthritis pain and hypertension simultaneously. "